PubRank

William J Martin

Author PubWeight™ 69.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken) 2012 6.51
2 The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 2009 4.51
3 Selection of stem cells by using antibodies that target different CD34 epitopes yields different patterns of T-cell differentiation. Stem Cells 2006 1.91
4 Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behavior. Proc Natl Acad Sci U S A 2005 1.84
5 The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci 2002 1.82
6 Estimating the number of low-income americans exposed to household air pollution from burning solid fuels. Environ Health Perspect 2014 1.41
7 A role for the melanocortin 4 receptor in sexual function. Proc Natl Acad Sci U S A 2002 1.38
8 Amiodarone pulmonary toxicity. Clin Chest Med 2004 1.27
9 Relationship between sodium channel NaV1.3 expression and neuropathic pain behavior in rats. Pain 2005 1.16
10 An improved western blotting technique effectively reduces background. Electrophoresis 2002 1.16
11 Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs. Pain 2005 1.15
12 Evaluation of postoperative analgesia in a rat model of incisional pain. Contemp Top Lab Anim Sci 2003 1.14
13 Sodium channel blockade may contribute to the analgesic efficacy of antidepressants. J Pain 2006 1.13
14 Fasting enhances the response of arcuate neuropeptide Y-glucose-inhibited neurons to decreased extracellular glucose. Am J Physiol Cell Physiol 2009 1.12
15 Implementation of evidence-based asthma interventions in post-Katrina New Orleans: the Head-off Environmental Asthma in Louisiana (HEAL) study. Environ Health Perspect 2012 1.04
16 Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist. J Med Chem 2002 1.03
17 The behavioral and neuroanatomical effects of IB4-saporin treatment in rat models of nociceptive and neuropathic pain. Brain Res 2004 1.03
18 Indoor environmental exposures for children with asthma enrolled in the HEAL study, post-Katrina New Orleans. Environ Health Perspect 2012 0.99
19 The Head-off Environmental Asthma in Louisiana (HEAL) study--methods and study population. Environ Health Perspect 2012 0.98
20 Block of peripheral nerve sodium channels selectively inhibits features of neuropathic pain in rats. Mol Pharmacol 2005 0.92
21 Protection of human lung cells against hyperoxia using the DNA base excision repair genes hOgg1 and Fpg. Am J Respir Crit Care Med 2002 0.91
22 Alveolar macrophages from HIV-infected subjects are resistant to Mycobacterium tuberculosis in vitro. Am J Respir Cell Mol Biol 2003 0.90
23 Benzazepinone Nav1.7 blockers: potential treatments for neuropathic pain. Bioorg Med Chem Lett 2007 0.90
24 The voltage-gated sodium channel Nav1.9 is required for inflammation-based urinary bladder dysfunction. Neurosci Lett 2009 0.89
25 Household air pollution: a call for studies into biomarkers of exposure and predictors of respiratory disease. Am J Physiol Lung Cell Mol Physiol 2013 0.89
26 Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic pain. Bioorg Med Chem Lett 2007 0.89
27 Comparative genomic analyses in Asparagus. Genome 2005 0.89
28 An official American Thoracic Society workshop report: Climate change and human health. Proc Am Thorac Soc 2012 0.89
29 Effects of sildenafil on erectile activity in mice lacking neuronal or endothelial nitric oxide synthase. Br J Pharmacol 2002 0.88
30 Escherichia coli FPG and human OGG1 reduce DNA damage and cytotoxicity by BCNU in human lung cells. Am J Physiol Lung Cell Mol Physiol 2002 0.87
31 Airway delivery of silica increases susceptibility to mycobacterial infection in mice: potential role of repopulating macrophages. J Immunol 2009 0.86
32 Fibronectin facilitates Mycobacterium tuberculosis attachment to murine alveolar macrophages. Infect Immun 2002 0.86
33 Mitochondrial DNA-depleted A549 cells are resistant to bleomycin. Am J Physiol Lung Cell Mol Physiol 2012 0.86
34 Morphologic detection and functional assessment of reconstituted normal alveolar macrophages in the lungs of SCID mice. J Immunol 2002 0.86
35 Combination immunotherapy with clinical-scale enriched human gammadelta T cells, hu14.18 antibody, and the immunocytokine Fc-IL7 in disseminated neuroblastoma. Clin Cancer Res 2005 0.86
36 Influence of ligand binding kinetics on functional inhibition of human recombinant serotonin and norepinephrine transporters. J Pharmacol Toxicol Methods 2009 0.85
37 Imidazopyridines: a novel class of hNav1.7 channel blockers. Bioorg Med Chem Lett 2008 0.83
38 A disubstituted succinamide is a potent sodium channel blocker with efficacy in a rat pain model. Biochemistry 2004 0.82
39 Relative contributions of norepinephrine and serotonin transporters to antinociceptive synergy between monoamine reuptake inhibitors and morphine in the rat formalin model. PLoS One 2013 0.81
40 Translational research in environmental health sciences. Transl Res 2007 0.80
41 Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists. J Med Chem 2010 0.80
42 A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships. Bioorg Med Chem Lett 2012 0.80
43 Influence of postoperative analgesics on the development of neuropathic pain in rats. Comp Med 2003 0.80
44 Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist. Bioorg Med Chem Lett 2011 0.79
45 Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonists. Bioorg Med Chem Lett 2010 0.79
46 Substituted biaryl pyrazoles as sodium channel blockers. Bioorg Med Chem Lett 2010 0.79
47 An official ATS conference proceedings: advances in small-animal imaging application to lung pathophysiology. Proc Am Thorac Soc 2008 0.79
48 Substituted biaryl oxazoles, imidazoles, and thiazoles as sodium channel blockers. Bioorg Med Chem Lett 2010 0.79
49 Surfactant protein A decreases nitric oxide production by macrophages in a tumor necrosis factor-alpha-dependent mechanism. Am J Respir Cell Mol Biol 2003 0.78
50 Relationship between the firing frequency of injured peripheral neurons and inhibition of firing by sodium channel blockers. J Pain 2006 0.78
51 Reversal of neuropathic pain by alpha-hydroxyphenylamide: a novel sodium channel antagonist. Neuropharmacology 2006 0.78
52 Discovery of (2S)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-4-methyl-2-piperazinecarboxamide (MB243), a potent and selective melanocortin subtype-4 receptor agonist. Bioorg Med Chem Lett 2005 0.78
53 Discovery and activity of (1R,4S,6R)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-2-methyl-2-azabicyclo[2.2.2]octane-6-carboxamide (3, RY764), a potent and selective melanocortin subtype-4 receptor agonist. Bioorg Med Chem Lett 2005 0.78
54 Synthesis and SAR of 1,2-trans-(1-hydroxy-3-phenylprop-1-yl)cyclopentane carboxamide derivatives, a new class of sodium channel blockers. Bioorg Med Chem Lett 2005 0.77
55 Discovery of a novel class of biphenyl pyrazole sodium channel blockers for treatment of neuropathic pain. Bioorg Med Chem Lett 2010 0.76
56 Medical risks of wilderness hiking. Am J Med 2003 0.76
57 Preclinical efficacy of THRX-200495, a dual pharmacology muscarinic receptor antagonist and β(2)-adrenoceptor agonist (MABA). Pulm Pharmacol Ther 2012 0.76
58 Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonist. Bioorg Med Chem Lett 2010 0.75
59 Currying favor with central inhibitory circuits. Focus on: "effects of TRPA1 agonists mustard oil and cinnamaldehyde on lumbar wide-dynamic range neuronal responses to innocuous and noxious cutaneous stimuli in rats". J Neurophysiol 2007 0.75
60 Science is dispassionate, we are told. Ann Am Thorac Soc 2013 0.75
61 Estimating the number of vulnerable people in the United States exposed to residential wood smoke: Rogalsky et al. Respond. Environ Health Perspect 2015 0.75
62 Direct leukocyte migration across pulmonary arterioles and venules into the perivascular interstitium of murine lungs during bleomycin injury and repair. Am J Pathol 2011 0.75
63 Synthetic liposomes are protective from bleomycin-induced lung toxicity. Am J Physiol Lung Cell Mol Physiol 2011 0.75
64 Novel cyclopentane dicarboxamide sodium channel blockers as a potential treatment for chronic pain. Bioorg Med Chem Lett 2005 0.75
65 Abdominal closure for a free transverse rectus abdominis myocutaneous flap: macrosurgery's importance in microsurgery. Aesthetic Plast Surg 2006 0.75
66 Chilean miners and biomedical research: a modest proposal. Am J Respir Crit Care Med 2010 0.75
67 Discovery of a novel class of isoxazoline voltage gated sodium channel blockers. Bioorg Med Chem Lett 2009 0.75
68 Translating translational biomedicine for environmental health. Environ Health Perspect 2006 0.75
69 Application of the classical Einthoven model of bronchoconstriction to the study of inhaled bronchodilators in rodents. J Pharmacol Toxicol Methods 2010 0.75
70 1-Amino-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid as a Tic mimetic: application in the synthesis of potent human melanocortin-4 receptor selective agonists. Bioorg Med Chem Lett 2005 0.75
71 Discovery of isoxazole voltage gated sodium channel blockers for treatment of chronic pain. Bioorg Med Chem Lett 2009 0.75
72 Focusing on global environmental health. Environ Health Perspect 2006 0.75
73 Global warming: a challenge to all American Thoracic Society members. Am J Respir Crit Care Med 2008 0.75
74 Discovery of potent and use-dependent sodium channel blockers for treatment of chronic pain. Bioorg Med Chem Lett 2005 0.75
75 3-Amino-1,5-benzodiazepinones: potent, state-dependent sodium channel blockers with anti-epileptic activity. Bioorg Med Chem Lett 2008 0.75